Medicines and health products news
The World Health Organization in Viet Nam (WHO) and the government of Viet Nam join hands to organize the first national Antibiotic Awareness Week, which will run on 16-22 November. Antimicrobial resistance in Viet Nam is affecting the health of the population and weakening the health care system. In 2013 Viet Nam became the first country in WHO’s Western Pacific Region to approve a national action plan to combat drug resistance. In observing the first Antibiotics Awareness Week Viet Nam is reiterating its commitment to combat Antibiotics resistance.
India aims to become a watchdog for drug safety in the South East Asia Region, according to the country’s Minister for Health and Family Welfare, J. P. Nadda. The announcement came at the WHO annual meeting of national pharmacovigilance centres in New Delhi on 4-6 November.
A website of up-to-date medicine prices in Peru is benefiting not just patients, but policy makers and the private sector.
The ‘Observatorio de Precios de Medicamentos’ (medicines price observatory) was the brain child of civil society, the pharmaceutical sector and government representatives involved in the Medicines Transparency Alliance.
The harmonisation of pharmaceutical standard setting is a critical component of facilitating access to safe and effective quality medicines. It is all the more important as trade becomes more globalised and medicines are manufactured and distributed internationally.
Minister of Health of Viet Nam signs Antimicrobial resistance pledge
Latest ketamine evidence under review this week
A possible boost for patient safety in South-East Asia region
Promoting quality medicines and saving lives
WHO publication on trade and health now available
WHO, WIPO and WTO to reflect on lessons from
20 years of TRIPS and public health
Meeting of World Pharmacopoeias in China to benefit the world’s
WHO, EU, EMA agreement to improve quality and safety of medicines